Medication info
Pyridazole Tablet 20mg (Rabeprazole Sodium)

Pyridazole Tablet 20mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
KMS Pharmaceutical Co., Ltd.
Appearance
Light yellow round enteric-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu×2)
Approval status
Active

MFDS item code 200611325 · Notified 2006.11.20 · Insurance code 654701060

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition is not cured after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms have resolved, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted according to individual patient needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Administer with caution because hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
KMS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This drug is used for the treatment of ulcers in the stomach and duodenum, particularly gastric ulcers and duodenal ulcers. It also helps alleviate symptoms associated with erosive or ulcerative gastroesophageal reflux disease (GERD). In cases of recurrent GERD, it may be used as a maintenance therapy. For patients with gastrointestinal ulcers caused by Helicobacter pylori infection, it is administered in combination with antibiotics to enhance treatment efficacy. It is also used for the treatment of conditions such as Zollinger-Ellison syndrome associated with excessive gastric acid secretion. This drug effectively improves gastrointestinal disorders.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition is not cured after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms have resolved, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted according to individual patient needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Administer with caution because hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This drug should not be used in patients who are allergic to certain ingredients or benzimidazole derivatives. Also, when used in combination with amoxicillin or clarithromycin for the eradication of Helicobacter pylori, it should not be administered if the patient is allergic to those antibiotics. Patients taking specific heart-related medications or antivirals, as well as pregnant or breastfeeding women, should not use this drug. Patients with liver disease, elderly patients, or those with a history of drug allergies should use this drug cautiously. This drug contains specific colorant ingredients, which may require caution in individuals allergic to those components. If any hypersensitivity reactions such as rash or itching occur during use, discontinuation should be immediate. Regular blood tests are required as there may be changes in red blood cell or white blood cell counts. Liver function tests should also be conducted regularly as signs of liver function abnormalities may occur. Various adverse reactions, including heart-related symptoms or changes in blood pressure, gastrointestinal issues, and neurological symptoms, have been reported; therefore, caution is required if symptoms occur. Respiratory symptoms such as pneumonia or difficulty breathing may occur, and if any unusual signs are present, immediate consultation with a healthcare professional is necessary. Side effects such as myalgia, arthralgia, skin rashes, vision abnormalities, and urinary tract problems may occur. Long-term use may increase the risk of osteoporosis and fractures; hence caution is needed for prolonged treatment. Hypomagnesemia may rarely occur, necessitating periodic checks of magnesium levels when taken for a long time or in combination with certain medications. This drug strongly suppresses gastric acid secretion, which may slightly increase the risk of bacterial infections in the gastrointestinal tract. Caution is advised when driving or operating machinery, as drowsiness or dizziness may occur. There may be drug interactions, so always consult with a healthcare professional regarding concomitant medications, especially when used with antibiotics, antivirals, and anticoagulants. This drug should not be used during pregnancy or breastfeeding, and its safety has not been established. Elderly patients should be particularly careful due to a higher potential for side effects arising from reduced liver function. Safety in children has not been established, and its use is not recommended. The tablet should be swallowed whole without chewing or crushing, and it should be stored out of reach of children. No specific antidote exists for overdose; appropriate treatment should be provided based on symptoms. Long-term use may affect the absorption of vitamin B12, necessitating periodic checks. Symptoms of autoimmune diseases such as lupus erythematosus may appear in the skin or systemically; any unusual symptoms should be reported to healthcare professionals immediately. It is important to inform physicians about this drug before any specific tumor marker tests, as it may affect those tests. Serious kidney conditions such as acute interstitial nephritis may occur, and if any kidney-related symptoms develop, discontinuation should be immediate.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, hepatic dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, melena, anorexia, cholelithiasis, oral ulceration, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenosis, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, asthenia, irritability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, increased blood volume, decreased strength in limbs, sensory impairment, decreased grip strength, language confusion, staggering, delirium, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonicity, neuralgia, myoclonus, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal clouding, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, anorexia, neck stiffness, phototoxic reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This helps to preserve the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Light yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu×2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.